ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

GAO: FDA Data On Drug Shortages Inadequate

February 21, 2014

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

NIH Consensus Conference Agenda, Registration Online.

September 1, 2000